Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
Social support and being part of social groups can improve psychological wellbeing among brain tumour patients, a new study has found.
Psoriasis with arthritis (PsA) appears to significantly increase the risk of hearing impairment, which partially facilitates an association with aggravated psychiatric outcomes, a new study has found.
Anxiety and depression strongly determine those who complain of chronic insomnia with or without quantitative sleep impairment measurements, reports a recent study.
An 8-week attention training programme using brain-computer interface (BCI) can help improve inattentive symptoms in children with attention deficit hyperactivity disorder (ADHD), thus providing a potential nonpharmacologic option for treating ADHD, a local study finds.
The use of serotonin norepinephrine reuptake inhibitors (SNRIs), but not selective serotonin reuptake inhibitors, to treat acute-phase major depressive disorder in elderly patients is associated with a higher risk of adverse events, a recent meta-analysis has shown.
Dissatisfaction with body image is common among men receiving androgen deprivation therapy (ADT), a new study has shown. Exercise is seen as a means to counterbalance the side effect of treatment and improve mood.
A mother contracting an infection while pregnant may raise the risk of autism and depression during the child’s life, but not bipolar disorder and psychosis, according to a recent study.
Special Reports
Globally, one in four people will be affected by psychiatric or neurological disorders during their lifetime.1 With an estimated affected population of 450 million people, mental disorders are among the leading causes of ill-health and disability worldwide.1 At the recent Lundbeck Neuroscience Symposium held at Hilton Kota Kinabalu from 3–5 November 2017, three renowned key opinion leaders from the field of psychiatry shared their insights into the optimal management of bipolar disorder and schizophrenia.
At a recent Lundbeck Neuroscience Symposium at Hilton Kota Kinabalu, Professor Bernhard Baune discussed important clinical considerations in the management of behavioural and psychological symptoms of dementia (BPSD), focussing on the role of memantine hydrochloride (Ebixa®; Lundbeck).
In this issue of MIMS PsychiatrySupplement, we bring you clinical updates related to managing depression and optimizing functional recovery in patients with depression, as well as a symposium highlight of the Lundbeck Malaysia Neuroscience Symposium.
On 6 November 2016, in conjunction with the first year anniversary of vortioxetine (Brintellix®, Lundbeck) in Malaysia, two distinguished speakers, Professor Gin S Malhi and Dr Pranab Kalita shared updates on depression and the use of vortioxetine in order to help patients with major depressive disorders (MDD) to return to their premorbid functional states. The session was followed by three case presentations.
Conference Reports
Multidomain intervention which includes nutrition, exercise, cognitive training and vascular risk monitoring is effective in preventing dementia, findings from the FINGER study have shown.
_1_2_Square.jpg)
Use of a ginkgo biloba extract on top of standard preventive treatment is shown to improve cognitive function and overall condition after acute ischaemic stroke.
